Elizabeth Luis
75 works · 3,564 citations · h-index 24
Top works
- Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
- EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer
- Selective Detection of Membrane Proteins Without Antibodies
- Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
- Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models
- Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing
- Robo4 Maintains Vessel Integrity and Inhibits Angiogenesis by Interacting with UNC5B
- Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
- Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice
- Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
- Molecular basis for negative regulation of the glucagon receptor
- Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer
- E-Cadherin Couples Death Receptors to the Cytoskeleton to Regulate Apoptosis
- Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex
- Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1
- An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
- Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor
- An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma